Efficacy of intravitreal bevacizumab for the treatment of Zone I Type 1 retinopathy of prematurity

Efficacy of intravitreal bevacizumab for the treatment of Zone I Type 1 retinopathy of prematurity

Purpose: To describe the efficacy of intravitreal bevacizumab for the treatment of type 1 retinopathy of prematurity (ROP) in zone I. Methods: Preterm infants with type 1 ROP in zone I (zone I ROP, any stage with plus disease or zone I ROP, stage 3 without plus disease) were enrolled in this prospec...

Full description

Bibliographic Details
Main Authors: Reza Karkhaneh, Hamidreza Torabi, Alireza Khodabande, Ramak Roohipoor, Mohammad Riazi-Esfahani
Format: Article
Language:English
Published: Knowledge E 2018-01-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Retinopathy of Prematurity; Zone I; Intravitreal Bevacizumab
Anti-vascular Endothelial Growth Factor; Treatment
Online Access:http://www.jovr.org/article.asp?issn=2008-322X;year=2018;volume=13;issue=1;spage=29;epage=33;aulast=

Internet

http://www.jovr.org/article.asp?issn=2008-322X;year=2018;volume=13;issue=1;spage=29;epage=33;aulast=

Similar Items